Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location-Reference-Cited by-同舟云学术

Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location

Published:2018-01 Issue:1 Volume:93 Page:40-47
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Janczak Dawid T.,Mimier Malgorzata K.,McBane Robert D.,Kamath Patrick S.,Simmons Benjamin S.,Bott-Kitslaar Dalene M.,Lenz Charles J.,Vargas Emily R.,Hodge David O.,Wysokinski Waldemar E.

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Heart disease and stroke statistics—2016 update: a report from the American Heart Association;Mozaffarian;Circulation,2016

2. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study;Heit;Arch Intern Med,2002

3. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study;Heit;Arch Intern Med,2000

4. Reasons for the persistent incidence of venous thromboembolism;Heit;Thromb Haemost,2017

5. The association of active cancer with venous thromboembolism location: a population-based study;Tafur;Mayo Clin Proc,2011

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing clinical outcomes of vitamin K antagonists vs non-vitamin K antagonists in anticoagulant therapy for mesenteric venous thrombosis;Journal of Vascular Surgery: Venous and Lymphatic Disorders;2024-09

2. Renal Vein Thrombosis Secondary to Pyelonephritis: Targeting a Thrombo-Inflammatory Entity;Clinics and Practice;2024-06-09

3. Structured benefit–risk assessment for enoxaparin, in the context of its label extension, for the extended treatment of deep vein thrombosis and pulmonary embolism, and prevention of its recurrence in patients with active cancer;Pharmacoepidemiology and Drug Safety;2024-04-29

4. Diagnostic conundrum: massive portal vein pathology in a young patient – benign or malignant?;ANZ Journal of Surgery;2024-03-07

5. Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations;Thrombosis Research;2024-02